892 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Recruiting Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cyclophosphamide;   Biological: DRibble vaccine;   Drug: Imiquimod;   Drug: GM-CSF;   Biological: HPV vaccine
22 Recruiting HYPAZ: Hypertension Induced by Pazopanib
Conditions: Renal Cell Carcinoma;   Soft Tissue Sarcoma;   Glioblastoma;   Ovarian Cancer;   Cervical Cancer;   Breast Cancer;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Pancreatic Cancer;   Melanoma;   Gastrointestinal Cancer
Intervention: Drug: Pazopanib
23 Not yet recruiting Pazopanib in Molecularly Selected Patients With Advanced NSCLC
Conditions: Carcinoma, Non-Small Cell Lung;   Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer
Intervention: Drug: Pazopanib
24 Recruiting Consolidation Pembrolizumab (MK-3475), Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Pembrolizumab
25 Recruiting Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
Conditions: Colorectal Cancer;   Gastric Adenocarcinoma;   Esophageal Cancer;   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Ovarian Epithelial Cancer;   Breast Cancer;   Hormone-refractory Prostate Cancer;   Pancreatic Ductal Adenocarcinoma;   Head and Neck Cancers- Squamous Cell;   Renal Cell Cancer;   Bladder Cancer;   Cervical Cancer;   Endometrial Cancer
Intervention: Drug: IMMU-132
26 Unknown  Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gemcitabine, UFT
27 Recruiting Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: Locally Advanced Non-small Cell Lung Cancer
Intervention: Drug: vorinostat
28 Not yet recruiting Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors;   Ovarian Cancer;   Small Cell Lung Cancer
Interventions: Drug: Alisertib;   Drug: Paclitaxel
29 Not yet recruiting Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Biological: QBKPN SSI
30 Recruiting Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Concurrent platinum-based chemotherapy;   Radiation: Standard Radiotherapy, 60 Gy in 30 fractions.;   Radiation: Functional Lung Avoidance Radiotherapy, 60 Gy in 30 fractions
31 Recruiting AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung
Condition: Non-Small Cell Lung Cancer
32 Recruiting Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Conditions: Non Small Cell Lung Cancer;   Breast Cancer
Interventions: Drug: YPEG-rhG-CSF, 20μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle;   Drug: YPEG-rhG-CSF, 30μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle;   Drug: YPEG-rhG-CSF, 45μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle;   Drug: PEG-rhG-CSF, 100μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
33 Unknown  Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Biological: URLC10, TTK and KOC1
34 Recruiting A Phase 2 Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Patients With PD-L1 Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer - "BIRCH"
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: MPDL3280A
35 Unknown  The Method ISET (Insulation by Size of Epithelial Tumor Cells)
Condition: Non Small Cell Lung Cancer
Intervention: Biological: ISET Methode
36 Unknown  Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: nitroglycerin;   Drug: paclitaxel
37 Unknown  Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC
Condition: Advanced Non-Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Pemetrexed plus carboplatin
38 Recruiting A Study of Abemaciclib (LY2835219) in Participants With Previously Treated Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Abemaciclib;   Drug: Erlotinib
39 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
40 Recruiting Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
Condition: Stage IIIA Non-small Cell Lung Cancer
Interventions: Radiation: proton beam radiation therapy;   Drug: cisplatin;   Drug: etoposide;   Procedure: therapeutic conventional surgery

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years